Boston, MA, United States of America

Liyi Huang


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2020-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Liyi Huang in Antimicrobial Photodynamic Inactivation

Introduction

Liyi Huang is an accomplished inventor based in Boston, MA (US). He has made significant contributions to the field of antimicrobial treatments, holding 2 patents that address critical challenges in inhibiting harmful bacteria.

Latest Patents

Huang's latest patents include an innovative antimicrobial photodynamic inactivation procedure and system. This invention addresses the problem of incomplete inhibition of harmful cells and bacteria, as well as the short duration of time during which such cells may re-grow after photodynamic treatment. The solution involves exposing target bacteria to a multi-component photosensitizer material, which is created by adding a predetermined potentiating chemical to a conventional single-component photosensitizer. This process occurs prior to irradiating the target with light. The multi-component photosensitizer can be achieved by mixing the two chemical compositions or through sequential exposure of the bacteria to the single-component photosensitizer and the chosen potentiating chemical.

Career Highlights

Liyi Huang is currently associated with The General Hospital Corporation, where he continues to advance his research and innovations in the field of photodynamic therapy. His work is pivotal in developing effective treatments for bacterial infections.

Collaborations

Huang collaborates with notable colleagues, including Daniela Vecchio and Michael R Hamblin, who contribute to his research endeavors and innovations.

Conclusion

Liyi Huang's contributions to antimicrobial photodynamic inactivation represent a significant advancement in medical technology. His innovative approach to treating harmful bacteria showcases the potential for improved health outcomes through scientific research and collaboration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…